BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway
AUTOR(ES)
Strobel, Thomas
FONTE
The National Academy of Sciences of the USA
RESUMO
To investigate the role of BAX in chemotherapy-induced apoptosis, we transfected the SW626 human ovarian cancer cell line, which lacks functional p53, with a cDNA encoding for murine BAX. Immunoblotting revealed that BAX transfectants expressed a mean of 10-fold increased levels of BAX compared with neo-transfected control clones, with similar levels of BCL-2 and BCL-xL. The cytotoxicity of paclitaxel, vincristine, and doxorubicin was significantly enhanced in BAX transfectants compared with control clones, whereas the cytotoxicity profile of carboplatin, etoposide, and hydroxyurea was unchanged. Increased paclitaxel-induced cytotoxicity of BAX clones was associated with enhanced apoptosis, as assessed by morphologic and flow cytometric criteria. These data suggest that sufficient levels of BAX may bypass the need for upstream molecules such as p53 in the process of chemotherapy-induced apoptosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19500Documentos Relacionados
- p53-independent apoptosis induced by paclitaxel through an indirect mechanism
- Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
- Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis
- Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis.
- Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis
